We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Industry

‘Cannabist’ Founder Submits Bid to Buy the Franchise From the Denver Post

Ben AdlinPublished on May 3, 2018 · Last updated July 28, 2020

As news broke last week that the Denver Post had eliminated all editorial positions at its pioneering cannabis-focused vertical, The Cannabist, founding editor Ricardo Baca quietly announced, in a single sentence at the bottom of a press release, that he may be interested in buying the property.

“Mr. Baca, whose agency Grasslands is in early discussions with Post leadership about potentially purchasing The Cannabist should they decide to sell it, is available for interviews,” it said. That was all.

It was still early in the process. As Baca told Leafly in an interview Thursday, “I was talking to the editor of the Denver Post and reaching out to the CFO of the newspaper.” But the CFO, he said, wasn’t returning his messages.

Eventually a friend suggested that if Baca really wanted a reply, he should go ahead and submit an offer. So he did.

“All I care is that The Cannabist doesn’t die.”

“Sure enough, I heard back from him a few hours later,” Baca said, adding that the Post executive replied that while the company doesn’t discuss mergers and acquisitions, “if I wanted to submit a letter of intent, they’d consider it.”

By the end of this week, Baca told Leafly, that letter of intent will be in hands of the Post’s owners.

“It signals my intent to pay, with some very well-curated investors, X dollars for The Cannabist,” Baca said.

I made it official one hour ago, when I sent The Denver Post an official letter of intent. My offer to purchase The Cannabist is reasonable, and I look forward to hearing back from the newspaper’s leadership. Here’s @LeaflyNews‘ @badlin with the latest: https://t.co/iXTpFbOzRe

— Ricardo Baca (@bruvs) May 4, 2018

The Cannabist’s founding editor, who left the Post in December 2016 to launch cannabis communications agency Grasslands, wouldn’t reveal the value of X. He said he’s received interest from prospective investors both inside and outside the cannabis industry, and he’s in “a couple other conversations with traditional media outlets that sound very excited.”

“Right now I’m contemplating what might be best to guarantee a legitimate and successful future for The Cannabist,” he said. “No matter who owns this, it needs to be an independent source of journalism that holds all sides accountable.”

Baca clarified that it would “probably be me personally” buying The Cannabist as opposed to his PR firm as the original press release suggested. But he stressed that he’s exploring all available options.

“All I care is that The Cannabist doesn’t die,” he told Leafly. “I can’t handle a world that doesn’t have a Cannabist.”


Cannabist founding editor Ricardo Baca talks to Leafly News editors about the effort on the latest episode of Leafly’s weekly news podcast, the Roll-Up.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
cannabis mediaColoradoDenverthe cannabist
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles

The latest in Industry

  • Anacostia Organics: Cannabis with care in the capital image
    Anacostia Organics: Cannabis with care in the capital
    Leafly Staff
  • Delivered Inc.: A dispensary at your doorstep image
    Delivered Inc.: A dispensary at your doorstep
    Leafly Staff
  • Green Flash: Delivering Boston’s cannabis future image
    Green Flash: Delivering Boston’s cannabis future
    Leafly Staff
  • Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC image
    Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC
    Leafly Staff
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.